Evidence map›Paper›PMID 34114884›Full record

ArticleBioanalysis2021

Validation of high-throughput, semiquantitative solid-phase SARS coronavirus-2 serology assays in serum and dried blood spot matrices.

Leo Maritz, Nicholas J Woudberg, Amber C Bennett, Andreia Soares, Florian Lapierre, Justin Devine, Matti Kimberg, Patrick J Bouic

Open access · greenAbstract read
In one paragraph

Article in Bioanalysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. RSV Neutralizing Antibodies in Dried Blood.The Journal of infectious diseases · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Leo MaritzSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.
Nicholas J WoudbergSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.ORCID https://orcid.org/0000-0002-6089-7097
Amber C BennettSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.
Andreia SoaresSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.
Florian LapierreTrajan Scientific & Medical, 7 Argent Place, Ringwood, Victoria, 3134, Australia.ORCID https://orcid.org/0000-0003-0377-6069
Justin DevineSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.
Matti KimbergSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.
Patrick J BouicSynexa Life Sciences, 4 Kunene Circle, Montague Gardens, Cape Town, 7441, South Africa.
Astellas Pharma (Netherlands) · NLStellenbosch University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological AssayCOVID-19Dried Blood Spot TestingHealthy VolunteersHigh-Throughput Screening AssaysHumansReproducibility of ResultsSARS-CoV-2COVID-19dried blood spotELISAneutralizing antibodiesSARS-CoV-2serology

Identifiers

PMID34114884
PMCPMC8202508
OpenAlexW3166276048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.